Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-09-07
Original SEC Filing: Click here

---

Webplus: BSPM/20100907/8-K_1/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 12:30 pm ET XIANYANG, China, Sep. 7 – Biostar Pharmaceuticals, Inc. (Nasdaq:BSPM) (“Biostar” or “the Company”), Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules (“Xin Aoxing Capsules”), and a variety of pharmaceutical products, today announced that

---

---

Webplus: BSPM/20100907/8-K_1/1/000.htm SEC Original: biostarpharma8k090610.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): September 7, 2010 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 (Issuer Telephone Number) N/A (Former name or former address, if

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-09-07CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046